): +; 011203#45167899...dr hajar ballout what is next after metformin? controlling glycaemia &...

9
CME Credits 10 – 11 July 2020 Program Hilton Habtoor Grand Hotel Beirut, Lebanon www.lsedl.org ANNUAL CONGRESS 23 rd Cardio-metabolic, Thyroid and Pituitary Diseases of the Lebanese Society of Endocrinology, Diabetes and Lipids UNDER THE PATRONAGE OF His Excellency the Minister of Public Health Dr Hamad Hassan https://zoom.us/webinar/register/WN_SdTiaX4HRUuMxXUNGzlIgw Congress Sessions Live on ZOOM Platform Click on the below link to Register:

Upload: others

Post on 31-Jan-2021

4 views

Category:

Documents


0 download

TRANSCRIPT

  • CME Credits

    10 – 11 July 2020

    Program

    Hilton Habtoor Grand HotelBeirut, Lebanonwww.lsedl.org

    ANNUAL CONGRESS23rd

    Cardio-metabolic, Thyroid andPituitary Diseases

    of the Lebanese Society of Endocrinology, Diabetesand Lipids

    UNDER THE PATRONAGE OFHis Excellency the Minister ofPublic Health Dr Hamad Hassan

    https://zoom.us/webinar/register/WN_SdTiaX4HRUuMxXUNGzlIgw

    Congress Sessions Live on ZOOM PlatformClick on the below link to Register:

  • Dear Colleagues and Friends, On behalf of the organizing committee, it is my pleasure to invite you all to the 23rd annual congress of the Lebanese Society of Endocrinol-ogy, Diabetes and lipids (LSEDL) that will be held on the 10th – 11th July 2020 at Hilton Habtoor Grand Hotel – Sin El Fil. The 23rd annual congress of the LSEDL is one of the premier congress-es, gathering top-notch leaders from different endocrinology fields becoming an excellent opportunity for best-practice exchange be-tween colleagues. This year’s congress theme will be: “Cardiometabol-ic, Thyroid and Pituitary Diseases”. Bringing together the leading specialists and researchers from the Middle East and prominent experts from Europe, the 23rd annual LSEDL congress will foster practice updates and science convergence. As al-ways, our mission is to fulfill the scientific expectations of the Lebanese and international colleagues. I would like to express my sincere recog-nition to the eminent speakers who accepted our invitation to be part in this event and discuss key enriching topics to our expertise.

    The 23rd Annual Congress of the LSEDL promises a futuristic health care vision based on a medical legacy of excellence in health care and education.

    It is our greatest honor and deepest privilege to welcome you; thank-ing you for your contribution to the success of this distinguished scien-tific event.

    Looking forward to an interactive meeting. Paola atallahPresident of the Lebanese Society of Endocrinology, Diabetes and Lipids

    Welcome letter

  • President of the congressDr Paola ATALLAH

    executive committeePresident Dr Paola ATALLAHVice President Dr Akram ECHTAYSecretary Dr Maya BARAKETreasurer Dr Hajjar BALLOUTMembers Dr Abbas NASSER Dr Carole SAADE RIACHY Dr Haitham ABOU DAHER Dr Rita MEDLEJ Dr Yasmine AKLE organizing committeeChair Dr Haitham ABOU DAHERMembers Dr Abbas NASSER Dr Yasmine AKLE

    scientific committeeChair Dr Rita MEDLEJMembers Dr Akram ECHTAY Dr Carole SAADE RIACHY Dr Hajjar BALLOUT Dr Maya BARAKE Dr Paola ATALLAH Dr Selim JAMBART

    committee & sPeaKers

    international sPeaKersDr Andreas LIEBL - GermanyDr Carel LE ROUX - Ireland Dr Chantal MATHIEU - BelgiumDr Fadi NABHAN - USADr Frederick Johan RAAL - South Africa Dr Glen MATFIN - United KingdomDr Juan Pablo FRIAS - USA Dr Leszek CZUPRYNIAK - PolandDr Robert BUSH - USADr Stephan JACOB - GermanyDr Tina VILSBOLL - DenmarkDr Vera POPOVIC-BRKIC - Serbia

    local sPeaKersDr Dana EL MASRI Dr Hala AHMADIEHDr Hala KERBAGE Dr Mireille EL AMMDr Ramzi ALAMEDDINE Dr Rita NEMRDr Roy RAADDr Sami AZAR Dr Selim NASSER

  • 12h00-13h00

    13h00-13h30

    moderators

    13h30-13h55

    13h55-14h00

    moderators

    14h00-14h25

    14h25-14h30

    moderators14h30-14h55

    14h55-15h00

    moderators15h00-15h25

    15h25-15h30

    15h30-16h00

    fridaY 10 JulY 2020registration + Welcome lunch

    opening ceremony

    Dr Frida ATALLAH Dr Rafi POLADIAN male hypogonadism guidelines Q&a

    Dr Jocelyne EID FARESDr Kamal HIRBLIfellow challenging case Presentation:sglt2 inhibitor induced hypercalcemia Q&a

    Dr Elizabeth ABOU JAOUDErecent advances in cv risk reduction in type 2 diabetes managementQ&a

    Dr Marie Noel KALLAS CHEMALY updates on outcomes in type 2 diabetes Patients with heart failureQ&a

    coffee Break

    Dr Hala AHMADIEH

    Dr Dana EL MASRI

    Dr Leszek CzUPRYNIAK

    Dr Mireille EL AMM

    Dr Paola ATALLAH - LSEDL PresidentDr Charaf ABOU CHARAf - President of the Lebanese Order of PhysiciansDr Hamad HASSAN - Minister of Public Health

  • moderators16h00-16h25

    16h25-16h30

    moderators16h30-16h55

    16h55-17h00

    moderators

    17h00-17h25

    17h25- 17h30

    moderators

    17h30-17h55

    17h55-18h00

    moderators

    18h00-18h2518h25-18h30

    Dr Selim JAMBARTtriglyceride levels a Bystander or a marker? Persistent cardiovascular risk evolutionQ&a

    Dr Carole SAADEH RIACHYgetting to goal: evidence for fixed ratio combinations in the management of type 2 diabetes Q&a

    Dr Mohammad EL RAWAS Dr Hussam GHOSNradioactive iodine from diagnosis to treatmentQ&a

    Dr Grace JRADDr Marwan KRAYEMstress & Burnout among Physicians in times of crisis: screening & managementQ&a

    Dr Mona NASRALLAHDr Ghassan KADDOUHapproach to thyroid nodulesQ&a

    Dr Robert BUSCH

    Dr Juan Pablo FRIAS

    Dr Roy RAAD

    Dr Hala KERBAGE

    Dr fadi NABHAN

  • 08h30 – 09h00

    moderators

    09h00-09h25

    09h25-09h30

    moderators

    09h35-10h00

    10h00-10h05

    moderators10h10-10h35

    10h35 -10h40

    moderators10h45-11h10

    11h10-11h15

    11h15-11h45

    moderators11h45-12h10

    12h10-12h15

    registration

    Dr Ghada BAKHOSDr Georges HAJJPathologic assessment and molecular Biomarkers in the mangement of thyroid carcinomasQ&a

    Dr Charles SAABDr Georges KARAM growth hormone replacement in adultsQ&a

    Dr Dana SLEIMANtype 2 diabetes and cardiorenal risk: the role for early sglt2iQ&a

    Dr Hajar BALLOUTWhat is next after metformin? controlling glycaemia & BeyondQ&a

    coffee Break

    Dr Nancy NAKHOULvertis cv: adding to the un-derstanding of the sglt2-is Class with ErtugliflozinQ&a

    Dr Selim NASSER

    Dr Vera POPOVIC -BRKIC

    Dr Stephan JACOB

    Dr Tina VILSBOLL

    Dr Sami AzAR

    saturdaY 11 JulY 2020

  • moderators12h20-12h45

    12h45-12h50

    12h50-13h50

    moderators13h50-14h15

    14h15-14h20

    moderators14h25-14h50

    14h50-14h55

    moderators15h00- 15h25

    15h25- 15h30

    15h30-16h00

    moderators16h00-16h25

    16h25-16h30

    Dr Maya BARAKEobesity management: time to actQ&a

    lunch Break

    Dr Akram ECHTAYverifY & early treatment IntensificationQ&a

    Dr Rita Maria CHIDIAC WEHBEit is time to consider the range: a new Perspective on glycaemic controlQ&a

    Dr Mounzer SALEHdyslipidemia: a step towards achieving optimal treatment targets & cardiovascular PreventionQ&a

    coffee Break

    Dr Ali MOURADthe established role of dPP4i in the management of type 2 diabetesQ&a

    Dr Carel LE ROUX

    Dr Chantal MATHIEU

    Dr Andreas LIEBL

    Dr Frederick Johan RAAL

    Dr Rita NEMR

  • moderators

    16h35-17h00

    17h00-17h05

    moderators

    17h10-17h35

    17h35-17h40

    moderators17h45-18h10

    18h10-18h15

    Dr Emile ANDARYDr Marie Helene GHANNAGEautoimmune disease of the PituitaryQ&a

    Dr Rola ABOU KHALILDr Ghada BALLANthyroid eye disease- connecting endocrinology with ophthalmologyQ&a

    Dr Rita MEDLEJcardiorenal metabolic approach: a necessity in type 2 diabetes managementQ&a

    Dr Vera POPOVIC -BRKIC

    Dr Ramzi ALAMEDDINE

    Dr Glen MATfIN

    saturdaY 11 JulY 2020